2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57:1333-1342. PMID:
23172780
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362. PMID:
2523562
4. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399. PMID:
8245854
5. Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 2012;32:339-345. PMID:
22142261
7. Suresh RL, Kananathan R, Merican I. Chronic hepatitis C--a study of 105 cases between 1990-2000. Med J Malaysia 2001;56:243-247. PMID:
11771088
8. Buti M, San Miguel R, Brosa M, Cabasés JM, Medina M, Angel Casado M, et al. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C. J Hepatol 2005;42:639-645. PMID:
15826711
9. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-338. PMID:
12682882
11. Jaafar R, Isahak I, Wong KK, Rashid ZZ, Sulong A, Jaafar MH, et al. Prevalence and predisposing factors for hepatitis C virus in haemodialysis unit Universiti Kebangsaan Malaysia Medical Centre. BMC Proc 2011;5:P210.
12. Vicknasingam B, Narayanan S, Navaratnam V. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Drug Alcohol Rev 2009;28:447-454. PMID:
19594801
13. Duraisamy G, Zuridah H, Ariffin MY. Prevalence of hepatitis C virus antibodies in blood donors in Malaysia. Med J Malaysia 1993;48:313-316. PMID:
7514258
14. Lang TA, Secic M. How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers. New York: American College of Physicians; 2006. p 125-148.
15. Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 2006;74:756-762. PMID:
16970019
19. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562. PMID:
10451460
20. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714. PMID:
16702586
21. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18 Suppl 1:S11-S19.
22. Martins T, Narciso-Schiavon JL, Schiavon Lde L. Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 2011;57:107-112 (Portuguese). PMID:
21390467
25. Batchelder A, Masson CL, Sorensen J, Perlman D. Gender differences in hepatitis C risk behaviors. Drug Alcohol Depend 2015;146:e220.
26. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002;36:S93-S98. PMID:
12407581